Research ArticleArticle
Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome
Ann Knight, Karin Hjorton, Christer Sundström, Martin Höglund, Carin Backlin, Karin E. Smedby, Johan Askling and Eva Baecklund
The Journal of Rheumatology February 2015, jrheum.141104; DOI: https://doi.org/10.3899/jrheum.141104
Ann Knight
From the Department of Medical Sciences, Section of Rheumatology, and Department of Medical Sciences, Section of Hematology, and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala; Clinical Epidemiology Unit, and Rheumatology Unit, Department of Medicine, Solna; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. A. Knight, MD, PhD; K. Hjorton, MD; E. Baecklund, Assistant Professor; C. Backlin, PhD, Department of Medical Sciences, Section of Rheumatology; C. Sundström, Professor, Department of Immunology, Genetics and Pathology; M. Höglund, Assistant Professor, Department of Medical Sciences, Section of Hematology, Uppsala University; K.E. Smedby, MD, PhD, Clinical Epidemiology Unit, Department of Medicine, and Karolinska Institutet, Karolinska University Hospital; J. Askling, Professor, Clinical Epidemiology Unit, Rheumatology Unit, Department of Medicine, and Karolinska Institutet at Karolinska University Hospital. Address correspondence to Dr. A. Knight, Institute of Medical Sciences, Department of Rheumatology, Uppsala University Hospital, Uppsala, s-751 85, Sweden. E-mail: ann.knight@akademiska.se. Accepted for publication December 17, 2014.
Karin Hjorton
From the Department of Medical Sciences, Section of Rheumatology, and Department of Medical Sciences, Section of Hematology, and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala; Clinical Epidemiology Unit, and Rheumatology Unit, Department of Medicine, Solna; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. A. Knight, MD, PhD; K. Hjorton, MD; E. Baecklund, Assistant Professor; C. Backlin, PhD, Department of Medical Sciences, Section of Rheumatology; C. Sundström, Professor, Department of Immunology, Genetics and Pathology; M. Höglund, Assistant Professor, Department of Medical Sciences, Section of Hematology, Uppsala University; K.E. Smedby, MD, PhD, Clinical Epidemiology Unit, Department of Medicine, and Karolinska Institutet, Karolinska University Hospital; J. Askling, Professor, Clinical Epidemiology Unit, Rheumatology Unit, Department of Medicine, and Karolinska Institutet at Karolinska University Hospital. Address correspondence to Dr. A. Knight, Institute of Medical Sciences, Department of Rheumatology, Uppsala University Hospital, Uppsala, s-751 85, Sweden. E-mail: ann.knight@akademiska.se. Accepted for publication December 17, 2014.
Christer Sundström
From the Department of Medical Sciences, Section of Rheumatology, and Department of Medical Sciences, Section of Hematology, and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala; Clinical Epidemiology Unit, and Rheumatology Unit, Department of Medicine, Solna; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. A. Knight, MD, PhD; K. Hjorton, MD; E. Baecklund, Assistant Professor; C. Backlin, PhD, Department of Medical Sciences, Section of Rheumatology; C. Sundström, Professor, Department of Immunology, Genetics and Pathology; M. Höglund, Assistant Professor, Department of Medical Sciences, Section of Hematology, Uppsala University; K.E. Smedby, MD, PhD, Clinical Epidemiology Unit, Department of Medicine, and Karolinska Institutet, Karolinska University Hospital; J. Askling, Professor, Clinical Epidemiology Unit, Rheumatology Unit, Department of Medicine, and Karolinska Institutet at Karolinska University Hospital. Address correspondence to Dr. A. Knight, Institute of Medical Sciences, Department of Rheumatology, Uppsala University Hospital, Uppsala, s-751 85, Sweden. E-mail: ann.knight@akademiska.se. Accepted for publication December 17, 2014.
Martin Höglund
From the Department of Medical Sciences, Section of Rheumatology, and Department of Medical Sciences, Section of Hematology, and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala; Clinical Epidemiology Unit, and Rheumatology Unit, Department of Medicine, Solna; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. A. Knight, MD, PhD; K. Hjorton, MD; E. Baecklund, Assistant Professor; C. Backlin, PhD, Department of Medical Sciences, Section of Rheumatology; C. Sundström, Professor, Department of Immunology, Genetics and Pathology; M. Höglund, Assistant Professor, Department of Medical Sciences, Section of Hematology, Uppsala University; K.E. Smedby, MD, PhD, Clinical Epidemiology Unit, Department of Medicine, and Karolinska Institutet, Karolinska University Hospital; J. Askling, Professor, Clinical Epidemiology Unit, Rheumatology Unit, Department of Medicine, and Karolinska Institutet at Karolinska University Hospital. Address correspondence to Dr. A. Knight, Institute of Medical Sciences, Department of Rheumatology, Uppsala University Hospital, Uppsala, s-751 85, Sweden. E-mail: ann.knight@akademiska.se. Accepted for publication December 17, 2014.
Carin Backlin
From the Department of Medical Sciences, Section of Rheumatology, and Department of Medical Sciences, Section of Hematology, and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala; Clinical Epidemiology Unit, and Rheumatology Unit, Department of Medicine, Solna; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. A. Knight, MD, PhD; K. Hjorton, MD; E. Baecklund, Assistant Professor; C. Backlin, PhD, Department of Medical Sciences, Section of Rheumatology; C. Sundström, Professor, Department of Immunology, Genetics and Pathology; M. Höglund, Assistant Professor, Department of Medical Sciences, Section of Hematology, Uppsala University; K.E. Smedby, MD, PhD, Clinical Epidemiology Unit, Department of Medicine, and Karolinska Institutet, Karolinska University Hospital; J. Askling, Professor, Clinical Epidemiology Unit, Rheumatology Unit, Department of Medicine, and Karolinska Institutet at Karolinska University Hospital. Address correspondence to Dr. A. Knight, Institute of Medical Sciences, Department of Rheumatology, Uppsala University Hospital, Uppsala, s-751 85, Sweden. E-mail: ann.knight@akademiska.se. Accepted for publication December 17, 2014.
Karin E. Smedby
From the Department of Medical Sciences, Section of Rheumatology, and Department of Medical Sciences, Section of Hematology, and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala; Clinical Epidemiology Unit, and Rheumatology Unit, Department of Medicine, Solna; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. A. Knight, MD, PhD; K. Hjorton, MD; E. Baecklund, Assistant Professor; C. Backlin, PhD, Department of Medical Sciences, Section of Rheumatology; C. Sundström, Professor, Department of Immunology, Genetics and Pathology; M. Höglund, Assistant Professor, Department of Medical Sciences, Section of Hematology, Uppsala University; K.E. Smedby, MD, PhD, Clinical Epidemiology Unit, Department of Medicine, and Karolinska Institutet, Karolinska University Hospital; J. Askling, Professor, Clinical Epidemiology Unit, Rheumatology Unit, Department of Medicine, and Karolinska Institutet at Karolinska University Hospital. Address correspondence to Dr. A. Knight, Institute of Medical Sciences, Department of Rheumatology, Uppsala University Hospital, Uppsala, s-751 85, Sweden. E-mail: ann.knight@akademiska.se. Accepted for publication December 17, 2014.
Johan Askling
From the Department of Medical Sciences, Section of Rheumatology, and Department of Medical Sciences, Section of Hematology, and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala; Clinical Epidemiology Unit, and Rheumatology Unit, Department of Medicine, Solna; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. A. Knight, MD, PhD; K. Hjorton, MD; E. Baecklund, Assistant Professor; C. Backlin, PhD, Department of Medical Sciences, Section of Rheumatology; C. Sundström, Professor, Department of Immunology, Genetics and Pathology; M. Höglund, Assistant Professor, Department of Medical Sciences, Section of Hematology, Uppsala University; K.E. Smedby, MD, PhD, Clinical Epidemiology Unit, Department of Medicine, and Karolinska Institutet, Karolinska University Hospital; J. Askling, Professor, Clinical Epidemiology Unit, Rheumatology Unit, Department of Medicine, and Karolinska Institutet at Karolinska University Hospital. Address correspondence to Dr. A. Knight, Institute of Medical Sciences, Department of Rheumatology, Uppsala University Hospital, Uppsala, s-751 85, Sweden. E-mail: ann.knight@akademiska.se. Accepted for publication December 17, 2014.
Eva Baecklund
From the Department of Medical Sciences, Section of Rheumatology, and Department of Medical Sciences, Section of Hematology, and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala; Clinical Epidemiology Unit, and Rheumatology Unit, Department of Medicine, Solna; Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. A. Knight, MD, PhD; K. Hjorton, MD; E. Baecklund, Assistant Professor; C. Backlin, PhD, Department of Medical Sciences, Section of Rheumatology; C. Sundström, Professor, Department of Immunology, Genetics and Pathology; M. Höglund, Assistant Professor, Department of Medical Sciences, Section of Hematology, Uppsala University; K.E. Smedby, MD, PhD, Clinical Epidemiology Unit, Department of Medicine, and Karolinska Institutet, Karolinska University Hospital; J. Askling, Professor, Clinical Epidemiology Unit, Rheumatology Unit, Department of Medicine, and Karolinska Institutet at Karolinska University Hospital. Address correspondence to Dr. A. Knight, Institute of Medical Sciences, Department of Rheumatology, Uppsala University Hospital, Uppsala, s-751 85, Sweden. E-mail: ann.knight@akademiska.se. Accepted for publication December 17, 2014.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome
Ann Knight, Karin Hjorton, Christer Sundström, Martin Höglund, Carin Backlin, Karin E. Smedby, Johan Askling, Eva Baecklund
The Journal of Rheumatology Feb 2015, jrheum.141104; DOI: 10.3899/jrheum.141104
Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome
Ann Knight, Karin Hjorton, Christer Sundström, Martin Höglund, Carin Backlin, Karin E. Smedby, Johan Askling, Eva Baecklund
The Journal of Rheumatology Feb 2015, jrheum.141104; DOI: 10.3899/jrheum.141104